Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components
- Conditions
- Glioma
- Registration Number
- NCT00813787
- Lead Sponsor
- AHS Cancer Control Alberta
- Brief Summary
The purpose of this study is to see if a specialized imaging technique using MRI called multi-exponential T2 component analysis can reliably differentiate between normal brain and brain tumour.
- Detailed Description
Existing methods of contouring tumours for radiation therapy involve manual interpretations of qualitative diagnostic images. These methods, being qualitative, do not offer a consistent and reproducible platform for contouring, making it difficult to evaluate the effects of contouring choices on treatment outcome. T2 component analysis in MRI has the potential to offer a quantitive basis for identifying tumor tissue- this potential is investigated in this pilot study.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Eighteen years of age or older
- Clinical subjects must have not yet begun radiation therapy
- Must have signed our study-specific consent form
Exclusion Criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method T2 characteristics of glioma tissue versus normal Before radiotherapy treatment begins
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Cross Cancer Institute
🇨🇦Edmonton, Alberta, Canada